InBody Co.,Ltd (KOSDAQ:041830)

Market Cap	408.44B +35.8%
Revenue (ttm)	226.62B +18.5%
Net Income	32.83B +3.2%
EPS	2,626.56 +7.6%
Shares Out	12.19M
PE Ratio	12.75
Forward PE	11.78
Dividend	400.00 (1.19%)
Ex-Dividend Date	Mar 28, 2025

Volume	28,407
Average Volume	31,881
Open	34,250
Previous Close	34,350
Day's Range	32,200 - 34,250
52-Week Range	21,400 - 35,350
Beta	0.40
RSI	60.99
Earnings Date	Feb 20, 2026

About InBody Co.,Ltd

InBody Co.,Ltd provides body composition analysis solutions worldwide. It offers body composition analyzers, automatic blood pressure monitors, stadiometers, and body water analyzers, as well as InBody dial and bands. The company was formerly known as Biospace Co., Ltd. InBody Co.,Ltd was founded in 1996 and is headquartered in Seoul, South Korea.

• Industry: Medical - Specialties
• Sector: Healthcare
• Founded: 1996
• Employees: 342
• Stock Exchange: KOSDAQ
• Ticker Symbol: 041830

Financial Performance

In 2024, InBody Co.,Ltd's revenue was 204.46 billion, an increase of 20.03% compared to the previous year's 170.35 billion. Earnings were 33.14 billion, a decrease of -9.75%.